Camptothecin analogs as potent inhibitors of topoisomerase I
US5364858A · kind A · utility
22Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 1992 |
| Grant date | Nov 15, 1994 |
| Priority date | — |
| Expiry date | Dec 8, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for synthesizing camptothecin and camptothecin analogs using a novel hydroxyl-containing tricyclic intermediate and the camptothecin analogs produced by the process. The camptothecin analogs are effective inhibitors of topoisomerase.I and show antileukemic and anti-tumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.